Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06560632 |
| Title | Phase 1 Trial of RP-3467 Alone and in Combination With Olaparib in Participants With Advanced Solid Tumors (POLAR) |
| Acronym | POLAR |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Repare Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Participating Site #1025 | San Francisco | California | 94158 | United States | Details | |
| Participating Site # 1008 | New York | New York | 10032 | United States | Details | |
| Participating Site # 1004 | New York | New York | 10065 | United States | Details | |
| Participating Site # 1001 | Houston | Texas | 77030 | United States | Details |